# clm_05E33637AD96

subject: Vertex Pharmaceuticals (/record/vertex-pharmaceuticals.md)  
predicate: quarterly_revenue  
value: 1,724,305,000 United States dollar  
valid_from: 2021-03-31  
valid_to: 2021-06-30  
published: 2021-04-30  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_BA95AEDBE337  
last_updated: 2026-11-08  
cite: AsOf. "Vertex Pharmaceuticals quarterly revenue: 1,724,305,000 United States dollar", as of 2021-03-31 (until 2021-06-30). Claim clm_05E33637AD96, https://asof.is/claim/clm_05E33637AD96, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532021000015/0000875320-21-000015-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2021, filed 2021-04-30  

## Sources

- https://www.sec.gov/Archives/edgar/data/875320/000087532021000015/0000875320-21-000015-index.htm (primary, SEC EDGAR 10-Q Q1 FY2021, published 2021-04-30)

## Supersedes

- [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | quarterly_revenue | 1,538,271,000 United States dollar | valid 2020-09-30 to 2021-03-31 | conf 0.95 | superseded | superseded_by [clm_05E33637AD96](/claim/clm_05E33637AD96.md) | [clm_D38659C12AE8](/claim/clm_D38659C12AE8.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.